360biolabs, a BioAgilytix company, offers the full spectrum of bioanalytical lab services for small and large molecules in all phases of drug development, with the added benefits that come from conducting your early phase clinical trials in Australia.
As APAC’s most comprehensive speciality laboratory, we provide a single laboratory for all of your global clinical trial requirements. We support pharmacokinetic (PK) analysis (biologics, small molecules, peptides and proteins), a diverse range of pharmacodynamic (PD) endpoints (flow cytometry, biomarkers, molecular assays, ELISPOT, virological endpoints including neutralisation) and central lab services in a quality assured environment (GLP, GCP, ISO / IEC 17025). As BioAgilytix LLC’s Australian subsidiary, we provide a single solution for your global clinical trial requirements with laboratories in USA and Europe as well as Australia.